Systematic review and meta-analysis of coronary artery disease in liver cirrhosis

Coronary artery disease (CAD) is increasingly observed in patients with liver cirrhosis. However, data on the incidence and prevalence of CAD in cirrhotic patients are heterogeneous, and the association remains uncertain.

Post-Hoc: China tensions both help and hurt Illumina

In the souring US-China relationship, there are winners and losers. DNA sequencing giant Illumina is both. Illumina got bad news this week when China …

February 8, 2025

What factors are associated with readmission in pediatric survivors of acute respiratory distress syndrome (ARDS)?

Researchers explore the rates of readmission over the first year among children who survived acute respiratory distress syndrome.

September 12, 2023

Acepodia raises $100M financing to boost cell therapies

Acepodia, a clinical stage biotechnology company developing first-in-class cell therapies with its antibody-cell conjugation (ACC) and allogeneic gamma delta 2 T-cell platforms to address gaps

June 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.